跳至主要内容
临床试验/NCT03709602
NCT03709602已完成不适用

Social Determinants of HPV Vaccine Completion Among Adolescents

Duke University1 个研究点 分布在 1 个国家目标入组 3,076 人开始时间: 2019年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,076
试验地点
1
主要终点
Overall HPV Vaccine Completion Rates

研究概览

简要总结

The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • For adolescents, participants need to be between the ages 11 to 14 years.
  • Received 1 dose of the HPV vaccine series between January 2017 and December
  • For parents, there is no age limit required.
  • Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian.
  • Parents or legal guardians who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent.

排除标准

  • Parents with cognitive impairment.
  • Adolescents with cognitive impairment.
  • Adolescents emancipated from their parents or legal guardian
  • Pregnant adolescent girls.

结局指标

主要结局

Overall HPV Vaccine Completion Rates

时间窗: up to 14 months

Adolescents who completed the required HPV vaccine doses (e.g. two or three doses based on the CDC's vaccine administration guidelines for adolescents' ages 11 to 14 years) during the January 2017 to February 2019 observation period.

次要结局

  • HPV Vaccine Completion Within 14-Months(within 14 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

SDH of HPV Vaccine Completion | 临床试验